Logo-ps
Pharm Sci. 2023;29(1): 1-19. doi: 10.34172/PS.2022.23

Review Article

Modulation of Nrf2 by Activation of Estrogen Receptor β as a Therapeutic Strategy to Prevent Cancer Development and Overcome Inflammation-Related Drug Resistance in Breast Cancer

Emdormi Rymbai 1 ORCID, Deepa Sugumar 1, Jubie Selvaraj 2, Ram Kothandam 3, Divakar Selvaraj 1 * ORCID

Cited by CrossRef: 0


   Indexing & Abstracting:

    

   

     

 

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

 

 

Follower of ICMJE

Powered by: